Announced
Financials
Sources
Tags
Single Bidder
Friendly
renal care
Health Care Services
Acquisition
Sweden
health care
Private Equity
Majority
Cross Border
Private
Pending
Synopsis
Mubadala, an investment company, and G42, an artificial intelligence firm, agreed to acquire Diaverum, a health care provider, from Bridgepoint, a private equity firm, for $2bn. “Diaverum is an exceptional company providing vital treatments that enable patients suffering from chronic kidney disease to live fulfilling lives. Its pioneering digital care offering fully aligns with M42’s focus on leveraging advanced technological solutions to deliver precise, personalized patient care,” Hasan Jasem Al Nowais, Mubadala Health Chief Executive Officer.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.